GENOCEA BIOSCIENCES, INC.: cashflow_operating
| Value | {"amount": -33057000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2018-01-01 – 2018-09-30 |
| Status | current |
| Entity | GENOCEA BIOSCIENCES, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:23:53.831879+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b84d8dfb-09bf-478e-85ec-18fa9813660a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001457612-19-000133 · Open the official SEC filing →Retrieved: 2026-08-19T14:23:53.831879+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001457612/cashflow-operating/2018-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b84d8dfb-09bf-478e-85ec-18fa9813660a
History
- supersedes {"amount": -33057000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"} (evidence 0001457612-18-000112)